GLP-1R Expression in the Gut The transcriptional start site of the GLP-1R does not contain a TATA- or a CAAT-box element, however, it contains 3 putative Sp1 binding sites (Lankat-Buttgereit and Goke, 1997)
Wipe the rubber stopper of both the retatrutide vial and the bacteriostatic water vial with alcohol swabs
Patients should not rush dose increases and should communicate with their prescribers if side effects are limiting their ability to maintain adequate nutrition or physical activity
The question is whether the added glucagon receptor effects, including the heart rate increase, will enhance, diminish, or have no effect on that protection
These changes can help delay or even reverse the condition, depending on its severity
Muscle Loss Another concern with rapid weight loss is loss of lean muscle mass